300298 三諾生物
按盤價 
17.210 +0.070 (+0.408%)
17.210 +0.070 (+0.408%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.320 | 10.139 | 9.186 | 15.138 | 3.898 |
| 總資產報酬率 ROA (%) | 3.418 | 5.427 | 4.692 | 8.629 | 2.673 |
| 投入資產回報率 ROIC (%) | 4.482 | 6.996 | 5.805 | 10.151 | 3.015 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.906 | 54.880 | 53.544 | 52.888 | 59.965 |
| 營業利潤率 (%) | 5.114 | 8.980 | 6.776 | 9.506 | 5.898 |
| 息稅前利潤/營業總收入 (%) | 6.529 | 9.348 | 7.334 | 14.508 | 7.300 |
| 淨利潤/營業總收入 (%) | 4.423 | 7.784 | 4.825 | 12.415 | 4.532 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 60.355 | 101.678 | 132.064 | 71.831 | 196.037 |
| 價值變動淨收益/利潤總額(%) | 0.978 | -0.404 | 0.295 | 0.140 | -55.417 |
| 營業外收支淨額/利潤總額(%) | 7.418 | -0.940 | -10.641 | 30.244 | -0.796 | 償債能力分析 |
| 流動比率 (X) | 1.425 | 1.406 | 1.508 | 1.448 | 2.206 |
| 速動比率 (X) | 1.015 | 1.015 | 1.055 | 1.043 | 1.737 |
| 資產負債率 (%) | 41.192 | 38.178 | 41.442 | 46.041 | 32.771 |
| 帶息債務/全部投入資本 (%) | 26.534 | 24.347 | 29.825 | 34.058 | 19.434 |
| 股東權益/帶息債務 (%) | 263.860 | 295.077 | 221.812 | 177.687 | 392.403 |
| 股東權益/負債合計 (%) | 128.966 | 144.236 | 125.339 | 109.149 | 204.659 |
| 利息保障倍數 (X) | 6.498 | 20.692 | 6.063 | 16.488 | 5.040 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 45.540 | 44.501 | 46.426 | 35.445 | 33.813 |
| 存貨周轉天數 (天) | 107.643 | 116.301 | 123.867 | 96.269 | 122.548 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 25/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
